| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |